查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1704653

2025年全球體外肺部模型市場報告

In-Vitro Lung Model Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年體外肺模型市場規模將呈指數級成長。到 2029 年，這一數字將成長至 11.6 億美元，複合年成長率為 21.0%。預測期內的成長可歸因於藥物開發的需求、臨床前試驗的增加、對呼吸毒理學認知的不斷提高、對再生醫學的關注、對環境問題的日益關注以及老年人口的成長。預測期內的關鍵趨勢包括對藥物測試的需求不斷增加、3D 列印技術的進步、器官晶片技術的進步、人工智慧和機器學習的融合、感測器和監測設備的融合、非藥物應用的擴大以及針對特異性疾病的模型的開發。

預計臨床試驗的激增將在未來幾年推動體外肺模型市場的成長。臨床試驗是評估新醫療方法對人類的有效性的研究。臨床研究的成長是由對先進醫療治療的需求不斷成長、醫療保健需求不斷成長以及對複雜健康挑戰的創新解決方案的尋求所推動的。試管內，它提供了一個受控的環境來研究物質如何影響肺組織，並有助於測試藥物、評估毒性、模擬疾病和了解疾病機制。例如，根據美國臨床試驗註冊中心ClinicalTrials.gov的數據，截至2024年1月，全球整體註冊的臨床試驗數量為477,230項，高於2022年的437,508項。因此，越來越多的臨床試驗正在刺激體外肺模型市場的發展。

體外肺部模型市場的關鍵參與者正在開發 3D 呼吸組織模型，以增加生理相關性和模型複雜性。這些模型是透過在專門的環境中培養選定的呼吸細胞而創建的，從而使它們形成模擬呼吸系統功能和形態的3D結構。這為研究和藥物測試提供了一個更生理相關的平台。例如，2023年4月，美國生物技術公司MatTek Corporation推出了EpiNasal，這是一種由原代人類鼻上皮細胞製成的創新3D呼吸組織模型。 EpiNasal 再現了鼻上皮的3D結構和功能，包括產生黏液的杯狀細胞、功能性緊密連接和跳動的纖毛。 EpiNasal 的推出擴展了 MatTek 的 3D 呼吸組織模型範圍，為研究藥物、化學物質、病原體和消費品對人體呼吸系統的影響提供了全面的系統。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球體外肺模型PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球體外肺模型市場：成長率分析
  • 全球體外肺模型市場表現：規模與成長，2019-2024
  • 全球體外肺模型市場預測：規模與成長，2024-2029 年，2034 年
  • 體外肺模型的全球總目標市場（TAM）

第6章市場區隔

  • 全球體外肺模型市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 2D（2D）模型
  • 3D（3D）模型
  • 全球體外肺模型市場的應用、效能及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 藥物研發與毒理學研究
  • 生理學研究
  • 3D（3D）模型開發
  • 其他用途
  • 全球體外肺模型市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 學術研究所
  • 製藥和生物技術公司
  • 其他最終用戶
  • 全球體外肺模型市場2D (2D) 模型細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單層細胞培養
  • 共培養
  • 全球體外肺模型市場3D（3D）模型細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 球形體
  • 類器官
  • 晶片肺模型

第7章 區域和國家分析

  • 全球離體肺模型市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球離體肺模型市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 體外肺部模型市場：競爭格局
  • 體外肺模型市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Epithelix
  • The Charles Stark Draper Laboratory Inc.
  • STEMCELL Technologies
  • American Type Culture Collection（ATCC）
  • BioIVT
  • InSphero
  • Emulate Inc.
  • PhoenixBio Co. Ltd.
  • Newcells Biotech
  • CN Bio Innovations Ltd.
  • Mimetas
  • Cyfuse Biomedical KK
  • 3D Biotek LLC
  • AlveoliX AG
  • AxoSim Technologies LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年體外肺模型市場：提供新機會的國家
  • 2029年體外肺模型市場：細分市場帶來新機會
  • 2029年體外肺部模型市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30515

An in vitro lung model is a scientific construct devised to replicate the cellular, structural, and functional characteristics of the human lung within a controlled laboratory setting. These models empower researchers to explore disease progression, identify biomarkers, and evaluate treatment effectiveness. They serve as invaluable instruments for advancing our comprehension of lung biology, refining therapeutic approaches, and enhancing health outcomes.

The primary classifications of in vitro lung models include two-dimensional (2D) models and three-dimensional (3D) models. A 2D model presents a simplified depiction of lung cells and tissue on a flat surface, employed in fundamental research and preliminary substance testing. They find utility across various domains such as drug discovery, toxicology assessments, physiological investigations, as well as the advancement of three-dimensional (3D) model methodologies. These models are utilized by academic research institutions, pharmaceutical and biotechnology firms, among others.

The in vitro lung model market research report is one of a series of new reports from The Business Research Company that provides in vitro lung model market statistics, including the in vitro lung model industry global market size, regional shares, competitors with in vitro lung model market share, detailed in vitro lung model market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro lung model industry. These in vitro lung model market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in-vitro lung model market size has grown exponentially in recent years. It will grow from $0.44 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growing prevalence of respiratory diseases, increased focus on personalized medicine, growing interest in drug repurposing, emphasis on precision medicine approaches, growing awareness of environmental health risks.

The in-vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $1.16 billion in 2029 at a compound annual growth rate (CAGR) of 21.0%. The growth in the forecast period can be attributed to drug development needs, rise in preclinical testing, increasing awareness of respiratory toxicology, focusing on regenerative medicine, growing environmental concerns, increasing geriatric populations. Major trends in the forecast period include increased demand for drug testing, advancements in 3D printing technology, advancements in organ-on-chip technology, integration of AI and machine learning, integration of sensors and monitoring devices, expansion of applications beyond pharmaceuticals, development of disease-specific models.

The surge in clinical studies is anticipated to drive growth in the in vitro lung model market in the future. Clinical trials are investigations that evaluate the effectiveness of new medical approaches in human subjects. This increase in clinical studies is propelled by the growing demand for advanced medical treatments, rising healthcare needs, and the search for innovative solutions to complex health challenges. In vitro lung models play a crucial role in clinical trials by providing a controlled setting to examine how substances affect lung tissue, aiding in drug testing, assessing toxicity, modeling diseases, and understanding disease mechanisms. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, as of January 2024, there were 477,230 registered clinical trials globally, up from 437,508 in 2022. Consequently, the rise in clinical studies stimulates the in vitro lung model market.

Key players in the in vitro lung model market are developing 3D respiratory tissue models to enhance the physiological relevance and complexity of their models. These models are created by culturing selected respiratory cells in a specialized environment, allowing them to form a three-dimensional structure that mimics the function and morphology of the respiratory system. This provides a more physiologically relevant platform for research and drug testing. For example, in April 2023, MatTek Corporation, a US-based biotechnology company, launched EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. EpiNasal replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and beating cilia. The introduction of EpiNasal expands MatTek's range of 3D respiratory tissue models, offering a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

In July 2024, Tergus Pharma, a US-based end-to-end service provider for topical pharmaceutical products, merged with MedPharm Ltd. for an undisclosed amount. This strategic merger combines the strengths of both companies, allowing them to offer a comprehensive range of services, including commercial production and serialization, formulation development, in vitro testing, and clinical manufacturing, all within a single integrated organization. The merger enhances their capabilities in developing and manufacturing hormone-based and highly potent drugs at Tergus Pharma's GMP manufacturing facility in Durham, NC. MedPharm Ltd., based in the UK, specializes in providing in vitro models that use human tissue to simulate lung and nasal delivery systems.

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in-vitro lung model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Lung Model Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro lung model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro lung model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro lung model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Two-Dimensional (2D) Model; Three-Dimensional (3D) Model
  • 2) By Application: Drug Discovery And Toxicology Studies; Physiological Research; Three-Dimensional (3D) Model Development; Other Applications
  • 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures; Co-cultures
  • 2) By Three-Dimensional (3D) Model: Spheroids; Organoids; Lung-On-A-chip Models
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; PerkinElmer Inc.; Charles River Laboratories International Inc.; Varian Medical Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Lung Model Market Characteristics

3. In-Vitro Lung Model Market Trends And Strategies

4. In-Vitro Lung Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In-Vitro Lung Model Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In-Vitro Lung Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In-Vitro Lung Model Market Growth Rate Analysis
  • 5.4. Global In-Vitro Lung Model Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In-Vitro Lung Model Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In-Vitro Lung Model Total Addressable Market (TAM)

6. In-Vitro Lung Model Market Segmentation

  • 6.1. Global In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Two-Dimensional (2D) Model
  • Three-Dimensional (3D) Model
  • 6.2. Global In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Toxicology Studies
  • Physiological Research
  • Three-Dimensional (3D) Model Development
  • Other Applications
  • 6.3. Global In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users
  • 6.4. Global In-Vitro Lung Model Market, Sub-Segmentation Of Two-Dimensional (2D) Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monolayer Cell Cultures
  • Co-cultures
  • 6.5. Global In-Vitro Lung Model Market, Sub-Segmentation Of Three-Dimensional (3D) Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spheroids
  • Organoids
  • Lung-On-A-chip Models

7. In-Vitro Lung Model Market Regional And Country Analysis

  • 7.1. Global In-Vitro Lung Model Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In-Vitro Lung Model Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-Vitro Lung Model Market

  • 8.1. Asia-Pacific In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-Vitro Lung Model Market

  • 9.1. China In-Vitro Lung Model Market Overview
  • 9.2. China In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-Vitro Lung Model Market

  • 10.1. India In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-Vitro Lung Model Market

  • 11.1. Japan In-Vitro Lung Model Market Overview
  • 11.2. Japan In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-Vitro Lung Model Market

  • 12.1. Australia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-Vitro Lung Model Market

  • 13.1. Indonesia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-Vitro Lung Model Market

  • 14.1. South Korea In-Vitro Lung Model Market Overview
  • 14.2. South Korea In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-Vitro Lung Model Market

  • 15.1. Western Europe In-Vitro Lung Model Market Overview
  • 15.2. Western Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-Vitro Lung Model Market

  • 16.1. UK In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-Vitro Lung Model Market

  • 17.1. Germany In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-Vitro Lung Model Market

  • 18.1. France In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-Vitro Lung Model Market

  • 19.1. Italy In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-Vitro Lung Model Market

  • 20.1. Spain In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-Vitro Lung Model Market

  • 21.1. Eastern Europe In-Vitro Lung Model Market Overview
  • 21.2. Eastern Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-Vitro Lung Model Market

  • 22.1. Russia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-Vitro Lung Model Market

  • 23.1. North America In-Vitro Lung Model Market Overview
  • 23.2. North America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-Vitro Lung Model Market

  • 24.1. USA In-Vitro Lung Model Market Overview
  • 24.2. USA In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-Vitro Lung Model Market

  • 25.1. Canada In-Vitro Lung Model Market Overview
  • 25.2. Canada In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-Vitro Lung Model Market

  • 26.1. South America In-Vitro Lung Model Market Overview
  • 26.2. South America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-Vitro Lung Model Market

  • 27.1. Brazil In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-Vitro Lung Model Market

  • 28.1. Middle East In-Vitro Lung Model Market Overview
  • 28.2. Middle East In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-Vitro Lung Model Market

  • 29.1. Africa In-Vitro Lung Model Market Overview
  • 29.2. Africa In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-Vitro Lung Model Market Competitive Landscape And Company Profiles

  • 30.1. In-Vitro Lung Model Market Competitive Landscape
  • 30.2. In-Vitro Lung Model Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. In-Vitro Lung Model Market Other Major And Innovative Companies

  • 31.1. Epithelix
  • 31.2. The Charles Stark Draper Laboratory Inc.
  • 31.3. STEMCELL Technologies
  • 31.4. American Type Culture Collection (ATCC)
  • 31.5. BioIVT
  • 31.6. InSphero
  • 31.7. Emulate Inc.
  • 31.8. PhoenixBio Co. Ltd.
  • 31.9. Newcells Biotech
  • 31.10. CN Bio Innovations Ltd.
  • 31.11. Mimetas
  • 31.12. Cyfuse Biomedical K.K.
  • 31.13. 3D Biotek LLC
  • 31.14. AlveoliX AG
  • 31.15. AxoSim Technologies LLC

32. Global In-Vitro Lung Model Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Lung Model Market

34. Recent Developments In The In-Vitro Lung Model Market

35. In-Vitro Lung Model Market High Potential Countries, Segments and Strategies

  • 35.1 In-Vitro Lung Model Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In-Vitro Lung Model Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In-Vitro Lung Model Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer